Hosted on MSN1mon
Saluda Medical secures $100m for Evoke System commercialisation
Saluda Medical has completed a $100m financing ... The platform claims to operate by delivering spinal cord stimulation (SCS) therapy that senses and measures neural activation, with an aim ...
Science Daily8d
Spinal cord stimulation restores neural function, targets key feature of progressive neurodegenerative disease
Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle atrophy (SMA) progression and could be applied to other motoneuron diseases, ...
The Victoria Advocate9d
Saluda Medical Announces Presentation of New Clinical Data at the 2025 NANS Annual Meeting
MINNEAPOLIS, Feb. 5, 2025 /PRNewswire/ -- Saluda Medical ... of objective neurophysiological measurements in spinal cord stimulation (SCS) with evoked compound action potential (ECAP) dose ...